胶带夹板式睑缘缝合术治疗持续性角膜上皮缺损
这项回顾性介入病例系列研究纳入34眼(33例)持续性角膜上皮缺损(PCED)患者,评估胶带夹板式睑缘缝合术(TST)的疗效。结果显示29/34眼(85.3%)在22.5±24.3天内缺损愈合且无需额外干预,logMAR最佳矫正视力从1.11±0.41显著改善至0.83±0.70(P = .02)。作者认为这种简单、廉价、无创的技术可考虑用于PCED患者。
要点
- 34眼中29眼(85.3%)经TST后PCED愈合,无需额外干预,平均愈合时间22.5±24.3天。
- logMAR最佳矫正视力从1.11±0.41显著改善至0.83±0.70(P = .02)。
- 无TST相关并发症,2例患者因不适选择终止治疗。
核心结论
- TST使多种病因所致PCED在85.3%的患眼中获得愈合,并显示视力显著改善。
- 作者认为这种简单、廉价、无创的技术可考虑用于PCED患者。
研究设计与样本
- 回顾性介入病例系列,纳入在三级角膜门诊接受TST的连续PCED(持续14天或以上)患者。
- 纳入标准为角膜上皮缺损对绷带接触镜治疗无反应者,排除随访时间少于3个月者。
- 共纳入33例患者34眼,平均年龄62.9±17.8岁(范围27-90岁)。
主要发现
- PCED主要病因包括角膜移植术后(n = 15)、单纯疱疹病毒(n = 4)、神经 trophic 角膜(n = 4)、浅层角膜切除术(n = 3)、真菌性角膜炎(n = 2)、暴露性角膜病变(n = 2)、移植失败(n = 1)、周边溃疡性角膜炎(n = 1)、玫瑰痤疮(n = 1)和缝线脓肿(n = 1)。
- 从PCED出现至TST的平均±SD时间为58.9±106.3天(范围14-390天),PCED平均±SD面积为25.1±15.7 mm2(范围0.50-42.0 mm2)。
- TST后29/34眼(85.3%)在22.5±24.3天(范围2-105天)内PCED愈合且无需额外干预。
- logMAR最佳矫正视力从1.11±0.41显著改善至0.83±0.70(P = .02)。
- 无归因于TST的并发症,2例患者因不适选择终止治疗。
临床怎么用
- 作者认为这种简单、廉价、无创的技术可考虑用于PCED患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report outcomes of tape splint tarsorrhaphy (TST) for persistent corneal epithelial defects (PCED). DESIGN: Retrospective, interventional case series. METHODS: The study population was consecutive patients with a PCED (14 days or longer) treated at a tertiary cornea clinic with TST. Patients with a corneal epithelial defect that did not respond to treatment with a bandage contact lens were included. Patients with a follow-up time of less than 3 months were excluded. Time to PCED resolution was the main outcome measure. RESULTS: Thirty-four eyes of 33 patients (mean age 62.9 ± 17.8 years; range, 27-90 years) were included in this study. The main etiologies of the PCED were post keratoplasty (n = 15), herpes simplex virus (n = 4), superficial keratectomy (n = 3), neurotrophic cornea (n = 4), fungal keratitis (n = 2), exposure keratopathy (n = 2), failed graft (n = 1), peripheral ulcerative keratitis (n = 1), rosacea (n = 1), and stitch abscess (n = 1). Mean ± SD time from PCED presentation to TST was 58.9 ± 106.3 days (range, 14-390 days). The mean ± SD area of the PCED was 25.1 ± 15.7 mm2 (range, 0.50-42.0 mm2). After TST, resolution of the PCED was achieved in 29/34 eyes (85.3%) without the need for additional interventions within 22.5 ± 24.3 days (range, 2-105 days). The mean ± SD logMAR best-corrected visual acuity improved significantly from 1.11 ± 0.41 to 0.83 ± 0.70 (P = .02). There were no complications attributed to TST and 2 patients elected to discontinue due to discomfort. CONCLUSIONS: TST achieved resolution of PCEDs secondary to various etiologies in 85.3% of eyes, with significant improvement in vision demonstrated. This simple, inexpensive, noninvasive technique may be considered for patients with PCEDs.
引用
- Mimouni M, Liu ES, Din N, et al. Tape Splint Tarsorrhaphy for Persistent Corneal Epithelial Defects. Am J Ophthalmol. 2021. PMID: 34942108. doi:10.1016/j.ajo.2021.12.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。